Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CORT · against 588 other Healthcare companies listed in US-listed
Ranked #298 of 589 · scores higher than 49% of peers
Bars: peers in each 10-point band of the valuation score75 peers with a valuation score of 30–39, including CORT · Click a bar to see the companies
Mainly because of its EBITDA yield, which is weaker than most Healthcare peers.
| Metric | CORT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 0.5% | -4.3% | 66% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 0.1% | -0.8% | 53% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 1.2% | -2.3% | 63% | 20% | |
| Book yieldHigher is better · 587 reported | 8.0% | 25.9% | 22% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 254 | 89M USD | 33 | 31 | |
| 254 | 184M USD | 33 | 33 | |
| 254 | 186M USD | 33 | 52 | |
| 254 | 3.3B USD | 33 | 39 | |
| 298 | 8.9B USD | 32 | 51 | |
| 298 | 1.1B USD | 32 | 61 | |
| 298 | 871M USD | 32 | 53 | |
| 301 | 2.2B USD | 31 | 36 | |
| 301 | 3.1B USD | 31 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score